Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.
Cleland JG, Shelton R, Nikitin N, Ford S, Frison L, Grind M. Cleland JG, et al. Among authors: frison l. Eur J Heart Fail. 2007 Jun-Jul;9(6-7):730-9. doi: 10.1016/j.ejheart.2007.01.013. Epub 2007 Mar 13. Eur J Heart Fail. 2007. PMID: 17360232
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
Lip GY, Frison L, Halperin JL, Lane DA. Lip GY, et al. Among authors: frison l. J Am Coll Cardiol. 2011 Jan 11;57(2):173-80. doi: 10.1016/j.jacc.2010.09.024. Epub 2010 Nov 24. J Am Coll Cardiol. 2011. PMID: 21111555 Clinical Trial.
86 results